Different behaviors and different strains: Potential new ways to model bipolar disorder

Neuroscience and Biobehavioral Reviews

Volumn 31, Issue 6, 2007, Pages 850-857

  Einat, Haim ^a,b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b Deptartment of Psychology   (United States)

Author keywords

Aggression; Animal models; Facets of behavior; Hedonia; Mania; Risk taking; Strain differences

Indexed keywords

LITHIUM; VALPROIC ACID;

AGGRESSION; ANIMAL MODEL; BEHAVIOR; BIPOLAR DISORDER; BREEDING; C57BL 6 MOUSE; DISEASE MODEL; FISCHER 344 RAT; GENE MUTATION; HIGH RISK BEHAVIOR; LEWIS RAT; LITERATURE; MANIA; MENTAL DISEASE; MOUSE STRAIN; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVIEW; STRAIN DIFFERENCE; SWISS WEBSTER MOUSE; VALIDITY;

ANIMALS; BEHAVIOR, ANIMAL; BEHAVIORAL RESEARCH; BIPOLAR DISORDER; DISEASE MODELS, ANIMAL; MICE; MICE, INBRED STRAINS; RATS; RATS, INBRED STRAINS; SPECIES SPECIFICITY;

EID: 34548026724     PISSN: 01497634     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neubiorev.2006.12.001     Document Type: Review

References (78)

1. Agmo A., Medrano A., Garrido N., and Alonso P. GABAergic drugs inhibit amphetamine-induced distractibility in the rat. Pharmacology Biochemistry and Behavior 58 1 (1997) 119-126
2. Anand A., Verhoeff P., Seneca N., Zoghbi S.S., Seibyl J.P., Charney D.S., and Innis R.B. Brain SPECT imaging of amphetamine-induced dopamine release in euthymic bipolar disorder patients. American Journal of Psychiatry 157 7 (2000) 1108-1114
3. Antelman S.M., Caggiula A.R., Kiss S., Edwards D.J., Kocan D., and Stiller R. Neurochemical and physiological effects of cocaine oscillate with sequential drug treatment: possibly a major factor in drug variability. Neuropsychopharmacology 12 4 (1995) 297-306
4. Antelman S.M., Caggiula A.R., Kucinski B.J., Fowler H., Gershon S., Edwards D.J., Austin M.C., Stiller R., Kiss S., and Kocan D. The effects of lithium on a potential cycling model of bipolar disorder. Progress in Neuropsychopharmacology and Biological Psychiatry 22 3 (1998) 495-510
5. Bailey K.R., Rustay N.R., and Crawley J.N. Behavioral phenotyping of transgenic and knockout mice: practical concerns and potential pitfalls. Ilar Journal 47 2 (2006) 124-131
6. Belmaker R.H., Lerer B., Klein E., and Hamburger R. The use of behavioral methods in the search for compounds with lithium-like activity. In: Levy A., and Spiegelstein M.Y. (Eds). Behavioral Models and the Analysis of Drug Action (1982), Elsevier, Amsterdam 343-356
7. Berridge C.W., and Stalnaker T.A. Relationship between low-dose amphetamine-induced arousal and extracellular norepinephrine and dopamine levels within prefrontal cortex. Synapse 46 3 (2002) 140-149
8. Borison R.L., Sabelli H.C., Maple P.J., Havdala H.S., and Diamond B.I. Lithium prevention of amphetamine-induced 'manic' excitement and of reserpine-induced 'depression' in mice: possible role of 2-phenylethylamine. Psychopharmacology (Berl) 59 3 (1978) 259-262
9. Braw Y., Malkesman O., Merlender A., Bercovich A., Dagan M., Maayan R., Weizman A., and Weller A. Stress hormones and emotion-regulation in two genetic animal models of depression. Psychoneuroendocrinology 16 (2006) 16
10. Caggiula A.R., Antelman S.M., Kucinski B.J., Fowler H., Edwards D.J., Austin M.C., Gershon S., and Stiller R. Oscillatory-sensitization model of repeated drug exposure: cocaine's effects on shock-induced hypoalgesia. Progress in Neuropsychopharmacology and Biological Psychiatry 22 3 (1998) 511-521
11. Cohen H., Zohar J., Gidron Y., Matar M.A., Belkind D., Loewenthal U., Kozlovsky N., and Kaplan Z. Blunted HPA axis response to stress influences susceptibility to posttraumatic stress response in rats. Biological Psychiatry 59 12 (2006) 1208-1218 Epub 2006 Feb 3
12. Crawley J.N. Behavioral phenotyping of transgenic and knockout mice: experimental design and evaluation of general health, sensory functions, motor abilities, and specific behavioral tests. Brain Research 835 1 (1999) 18-26
13. Cryan J.F., and Mombereau C. In search of a depressed mouse: utility of models for studying depression-related behavior in genetically modified mice. Molecular Psychiatry 9 4 (2004) 326-357
14. Csaba G., and Karabelyos C. The effect of a single neonatal treatment (hormonal imprinting) with the antihormones, tamoxifen and mifepristone on the sexual behavior of adult rats. Pharmacological Research 43 6 (2001) 531-534
15. Ebstein R.P., Eliashar S., Belmaker R.H., Ben-Uriah Y., and Yehuda S. Chronic lithium treatment and dopamine-mediated behavior. Biological Psychiatry 15 3 (1980) 459-467
16. Einat H. Modelling facets of mania-new directions related to the notion of endophenotypes. Journal of Psychopharmacology 20 15 (2006) 715-722
17. Einat H. Establishment of a battery of simple models for facets of bipolar disorder: a practical approach to achieve increased validity, better screening and possible insights into endophenotypes of disease. Behavior Genetic 37 1 (2007) 244-255
18. Einat H., Karbovski H., Korik J., Tsalah D., and Belmaker R.H. Inositol reduces depressive-like behaviors in two different animal models of depression. Psychopharmacology (Berl) 144 2 (1999) 158-162
19. Einat H., Kofman O., and Belmaker R.H. Animal models of bipolar disorder: from a single episode to progressive cycling models. In: Myslobodsky M., and Weiner I. (Eds). Contemporary Issues in Modeling Psychopharmacology (2000), Kluwer Academic Publishers, Boston 165-180
20. Einat H., Belmaker R.H., Zangen A., Overstreet D.H., and Yadid G. Chronic inositol treatment reduces depression-like immobility of Flinders Sensitive Line rats in the forced swim test. Depression and Anxiety 15 3 (2002) 148-151
21. Einat H., Manji H.K., and Belmaker R.H. New approaches to modeling bipolar disorder. Psychopharmacology Bulletin 37 1 (2003) 47-63
22. Einat H., Yuan P., Gould T.D., Li J., Du J., Zhang L., Manji H.K., and Chen G. The role of the extracellular signal-regulated kinase signaling pathway in mood modulation. Journal of Neuroscience 23 19 (2003) 7311-7316
23. Einat H., Yuan P., and Manji H.K. Increased anxiety-like behaviors and mitochondrial dysfunction in mice with targeted mutation of the Bcl-2 gene: further support for the involvement of mitochondrial function in anxiety disorders. Behavioural Brain Research 165 2 (2005) 172-180 Epub 2005 Aug 10
24. El Khoury A., Gruber S.H., Mork A., and Mathe A.A. Adult life behavioral consequences of early maternal separation are alleviated by escitalopram treatment in a rat model of depression. Progress in Neuropsychopharmacology and Biological Psychiatry 30 3 (2006) 535-540 Epub 2006 Jan 18
25. Friedman E., Berman M., and Overstreet D. Swim test immobility in a genetic rat model of depression is modified by maternal environment: a cross-foster study. Developmental Psychobiology 48 2 (2006) 169-177
26. Gessa G.L., Pani L., Serra G., and Fratta W. Animal models of mania. In: Gessa G.L., Fratta W., Pani L., and Serra G. (Eds). Depression and Mania: from Neurobiology to Treatment vol. 49 (1995), Raven Press, New York 43-66
27. Geyer M.A., Krebs-Thomson K., Braff D.L., and Swerdlow N.R. Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review. Psychopharmacology (Berl) 156 2-3 (2001) 117-154
28. Gould T.D., and Gottesman I.I. Psychiatric endophenotypes and the development of valid animal models. Genes Brain and Behavior 5 2 (2006) 113-119
29. Gould T.D., Einat H., Bhat R., and Manji H.K. AR-A014418, a selective GSK-3 inhibitor, produces antidepressant-like effects in the forced swim test. International Journal of Neuropsychopharmacology (2004) 1-4
30. Gould, T.D., O'Donnell, K.C., Picchini, A.M., Manji, H.K., 2006. Differences in lithium attenuation of d-amphetamine hyperlocomotion: a mouse model for the genetics of clinical response to lithium. Neuropsychopharmacology. [Dec 6; Epub ahead of print].
31. Guitart X., Kogan J.H., Berhow M., Terwilliger R.Z., Aghajanian G.K., and Nestler E.J. Lewis and Fischer rat strains display differences in biochemical, electrophysiological and behavioral parameters: studies in the nucleus accumbens and locus coeruleus of drug naive and morphine-treated animals. Brain Research 611 1 (1993) 7-17
32. Hall F.S., Huang S., Fong G.W., Pert A., and Linnoila M. Effects of isolation-rearing on voluntary consumption of ethanol, sucrose and saccharin solutions in Fawn Hooded and Wistar rats. Psychopharmacology (Berl) 139 3 (1998) 210-216
33. Hasegawa S., Nishi K., Watanabe A., Overstreet D.H., and Diksic M. Brain 5-HT synthesis in the Flinders Sensitive Line rat model of depression: an autoradiographic study. Neurochemistry International 48 5 (2006) 358-366 Epub 2006 Jan 19
34. Hiscock, K., Linde, J., Einat, H., submitted. Black Swiss mice as a tentative model for mania.
35. Huey L.Y., Janowsky D.S., Judd L.L., Abrams A., Parker D., and Clopton P. Effects of lithium carbonate on methylphenidate-induced mood, behavior, and cognitive processes. Psychopharmacology (Berl) 73 2 (1981) 161-164
36. Kampov-Polevoy A.B., Matthews D.B., Gause L., Morrow A.L., and Overstreet D.H. P rats develop physical dependence on alcohol via voluntary drinking: changes in seizure thresholds, anxiety, and patterns of alcohol drinking. Alcoholism-Clinical and Experimental Research 24 3 (2000) 278-284
37. Kantor S., Anheuer Z.E., and Bagdy G. High social anxiety and low aggression in Fawn-Hooded rats. Physiology & Behavior 71 5 (2000) 551-557
38. Kato T. Molecular genetics of bipolar disorder. Neuroscience Research 40 2 (2001) 105-113
39. Kato T., Kuratomi G., and Kato N. Genetics of bipolar disorder. Drugs Today (Barc) 41 5 (2005) 335-344
40. Kavaliers M., Choleris E., and Colwell D.D. Brief exposure to female odors "emboldens" male mice by reducing predator-induced behavioral and hormonal responses. Hormones and Behavior 40 4 (2001) 497-509
41. Knapp R.J., Goldenberg R., Shuck C., Cecil A., Watkins J., Miller C., Crites G., and Malatynska E. Antidepressant activity of memory-enhancing drugs in the reduction of submissive behavior model. European Journal of Pharmacology 440 1 (2002) 27-35
42. Kosten T.A., and Ambrosio E. HPA axis function and drug addictive behaviors: insights from studies with Lewis and Fischer 344 inbred rats. Psychoneuroendocrinology 27 1-2 (2002) 35-69
43. Kucinski B.J., Antelman S.M., Caggiula A.R., Fowler H., Gershon S., and Edwards D.J. Cocaine-induced oscillation is conditionable. Pharmacology Biochemistry and Behavior 63 3 (1999) 449-455
44. Lerer B., Ebstein R.P., Felix A., and Belmaker R.H. Lithium amelioration of reserpine-induced hypoactivity in rats. International Pharmacopsychiatry 15 6 (1980) 338-343
45. Lesch K.P., and Mossner R. Inactivation of 5HT transport in mice: modeling altered 5HT homeostasis implicated in emotional dysfunction, affective disorders, and somatic syndromes. Handbook on Experimental Pharmacology 175 (2006) 417-456
46. Machado-Vieira R., Kapczinski F., and Soares J.C. Perspectives for the development of animal models of bipolar disorder. Progress in Neuropsychopharmacology and Biological Psychiatry 28 2 (2004) 209-224
47. Malatynska E., and Knapp R.J. Dominant-submissive behavior as models of mania and depression. Neuroscience and Biobehavioral Reviews 29 4-5 (2005) 715-737
48. Mayo-Michelson L., and Young G.A. Effects of chronic morphine administration and naloxone on EEG, EEG power spectra, and associated behavior in two inbred rat strains. Pharmacology Biochemistry and Behavior 42 4 (1992) 815-821
49. Miczek K.A., and O'Donnell J.M. Intruder-evoked aggression in isolated and nonisolated mice: effects of psychomotor stimulants and L-dopa. Psychopharmacology (Berl) 57 1 (1978) 47-55
50. Murphy D.L., Brodie H.K., Goodwin F.K., and Bunney Jr. W.E. Regular induction of hypomania by L-dopa in "bipolar" manic-depressive patients. Nature 229 5280 (1971) 135-136
51. Nestler E.J., Gould E., Manji H., Buncan M., Duman R.S., Greshenfeld H.K., Hen R., Koester S., Lederhendler I., Meaney M., Robbins T., Winsky L., and Zalcman S. Preclinical models: status of basic research in depression. Biological Psychiatry 52 6 (2002) 503-528
52. O'Brien W.T., Harper A.D., Jove F., Woodgett J.R., Maretto S., Piccolo S., and Klein P.S. Glycogen synthase kinase-3beta haploinsufficiency mimics the behavioral and molecular effects of lithium. Journal of Neuroscience 24 30 (2004) 6791-6798
53. O'Donnell, K.C., Gould, T.D., in press. The behavioral actions of lithium in rodent models: leads to develop novel therapeutics. Neuroscience and Biobehavioral Reviews, this issue.
54. O'Tuathaigh C.M., Babovic D., O'Meara G., Clifford J.J., Croke D.T., and Waddington J.L. Susceptibility genes for schizophrenia: Characterisation of mutant mouse models at the level of phenotypic behaviour. Neuroscience and Biobehavioral Reviews 16 (2006) 16
55. Overstreet D.H. Selective breeding for increased cholinergic function: development of a new animal model of depression. Biological Psychiatry 21 1 (1986) 49-58
56. Overstreet D.H., and Griebel G. Antidepressant-like effects of the vasopressin V1b receptor antagonist SSR149415 in the Flinders Sensitive Line rat. Pharmacology Biochemistry and Behavior 82 1 (2005) 223-227 Epub 2005 Sep 21
57. Overstreet D.H., Pucilowski O., Rezvani A.H., and Janowsky D.S. Administration of antidepressants, diazepam and psychomotor stimulants further confirms the utility of Flinders Sensitive Line rats as an animal model of depression. Psychopharmacology (Berl) 121 1 (1995) 27-37
58. Overstreet D.H., Keeney A., and Hogg S. Antidepressant effects of citalopram and CRF receptor antagonist CP-154,526 in a rat model of depression. European Journal of Pharmacology 492 2-3 (2004) 195-201
59. Overstreet D.H., Friedman E., Mathe A.A., and Yadid G. The Flinders Sensitive Line rat: a selectively bred putative animal model of depression. Neuroscience and Biobehavioral Reviews 29 4-5 (2005) 739-759 Epub 2005 Apr 22
60. Pare W.P. Stress ulcer susceptibility and depression in Wistar Kyoto (WKY) rats. Physiology & Behavior 46 6 (1989) 993-998
61. Porsolt R.D., Le Pichon M., and Jalfre M. Depression: a new animal model sensitive to antidepressant treatments. Nature 266 5604 (1977) 730-732
62. Porsolt R.D., Bertin A., and Jalfre M. "Behavioural despair" in rats and mice: strain differences and the effects of imipramine. European Journal of Pharmacology 51 3 (1978) 291-294
63. Porsolt R.D., Chermat R., Lenegre A., Avril I., Janvier S., and Steru L. Use of the automated tail suspension test for the primary screening of psychotropic agents. Archives Internationales de Pharmacodynamie et de Therapie 288 1 (1987) 11-30
64. Post R.M., and Weiss S.R. Sensitization, kindling, and anticonvulsants in mania. Journal of Clinical Psychiatry 50 Suppl (1989) 23-30 discussion 45-7
65. Prickaerts J., Moechars D., Cryns K., Lenaerts I., van Craenendonck H., Goris I., Daneels G., Bouwknecht J.A., and Steckler T. Transgenic mice overexpressing glycogen synthase kinase 3beta: a putative model of hyperactivity and mania. Journal of Neuroscience 26 35 (2006) 9022-9029
66. Ralph-Williams R.J., Paulus M.P., Zhuang X., Hen R., and Geyer M.A. Valproate attenuates hyperactive and perseverative behaviors in mutant mice with a dysregulated dopamine system. Biological Psychiatry 53 4 (2003) 352-359
67. Rasmussen K., Beitner-Johnson D.B., Krystal J.H., Aghajanian G.K., and Nestler E.J. Opiate withdrawal and the rat locus coeruleus: behavioral, electrophysiological, and biochemical correlates. Journal of Neuroscience 10 7 (1990) 2308-2317
68. Ricceri L., Moles A., and Crawley J. Behavioral phenotyping of mouse models of neurodevelopmental disorders: relevant social behavior patterns across the life span. Behavioural Brain Research 20 (2006) 20
69. Rondi-Reig L., Lemaigre Dubreuil Y., Martinou J.C., Delhaye-Bouchaud N., Caston J., and Mariani J. Fear decrease in transgenic mice overexpressing bcl-2 in neurons. Neuroreport 8 11 (1997) 2429-2432
70. Shaldubina A., Buccafusca R., Johanson R.A., Agam G., Belmaker R.H., Berry G.T., and Bersudsky Y. Behavioural phenotyping of sodium-myo-inositol cotransporter heterozygous knockout mice with reduced brain inositol. Genes and Brain Behavior 17 (2006) 17
71. Suzuki T., George F.R., and Meisch R.A. Differential establishment and maintenance of oral ethanol reinforced behavior in Lewis and Fischer 344 inbred rat strains. Journal of Pharmacology and Experimental Therapeutics 245 1 (1988) 164-170
72. Tecott L.H., and Nestler E.J. Neurobehavioral assessment in the information age. Nature Neuroscience 7 5 (2004) 462-466
73. Thierry B., Steru L., Simon P., and Porsolt R.D. The tail suspension test: ethical considerations. Psychopharmacology (Berl) 90 2 (1986) 284-285
74. Van Kammen D.P., and Murphy D.L. Attenuation of the euphoriant and activating effects of d- and l-amphetamine by lithium carbonate treatment. Psychopharmacologia 44 3 (1975) 215-224
75. Vit J.P., Clauw D.J., Moallem T., Boudah A., Ohara P.T., and Jasmin L. Analgesia and hyperalgesia from CRF receptor modulation in the central nervous system of Fischer and Lewis rats. Pain 121 3 (2006) 241-260 Epub 2006 Feb 21
76. Wei Q., Lu X.Y., Liu L., Schafer G., Shieh K.R., Burke S., Robinson T.E., Watson S.J., Seasholtz A.F., and Akil H. Glucocorticoid receptor overexpression in forebrain: a mouse model of increased emotional lability. Proceedings of the National Academy of Sciences, USA 101 32 (2004) 11851-11856 Epub 2004 Jul 27
77. Willner P., Towell A., Sampson D., Sophokleous S., and Muscat R. Reduction of sucrose preference by chronic unpredictable mild stress, and its restoration by a tricyclic antidepressant. Psychopharmacology (Berl) 93 3 (1987) 358-364
78. Willner P., Muscat R., and Papp M. An animal model of anhedonia. Clinical Neuropharmacology 15 Suppl 1 Pt A (1992) 550A-551A